Thomson Reuters, a major vendor of business intelligence services and technology spanning multiple industries, intends to divest its health care operations.
The New York-based company will use the proceeds to invest in its core markets including legal, tax and accounting, science and intellectual property, financial services, and media, according to a statement from CEO Thomas Glocer.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access